BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 315598)

  • 1. [Preliminary considerations on the intravenous use of Corynebacterium parvum in the treatment of solid neoplasms].
    Scheinberg MA; Sartori JP; de Pinho JG
    AMB Rev Assoc Med Bras; 1979 Apr; 25(4):139-40. PubMed ID: 315598
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological response in patients receiving Corynebacterium parvum therapy.
    Osborn DE; Castro JE
    Clin Oncol; 1977 Jun; 3(2):155-64. PubMed ID: 872468
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Immunological control of cancer.
    Lancet; 1975 Mar; 1(7905):502-3. PubMed ID: 46965
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Immunological control of cancer.
    Israel L; Edelstein R
    Lancet; 1975 Apr; 1(7913):979-10. PubMed ID: 48154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of neoplastic pleural effusion by intrapleural administration of Corynebacterium parvum vaccine].
    Krasucka-Kluźniak A; Krakówka P
    Pneumonol Pol; 1985 May; 53(5):240-7. PubMed ID: 4047949
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Side-effects of intravenous Corynebacterium parvum.
    Hamilton DN
    Lancet; 1975 Dec; 2(7947):1263. PubMed ID: 53755
    [No Abstract]   [Full Text] [Related]  

  • 7. The complications of intravenous Corynebacterium parvum infusion.
    Gill PG; Morris PJ; Kettlewell M
    Clin Exp Immunol; 1977 Nov; 30(2):229-32. PubMed ID: 606444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
    Yadeau R; Bates HA; Fortuny I
    Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of advanced ovarian malignancy with chemoimmunotherapy using autologous tumor and Corynebacterium parvum.
    Gusdon JP; Homesley HD; Jobson VW; Muss HB
    Obstet Gynecol; 1983 Dec; 62(6):728-35. PubMed ID: 6633998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy (DTIC and Corynebacterium parvum) for disseminated malignant melanoma.
    Karakousis CP; Didolkar MS; Han T
    Cancer Treat Rep; 1981; 65(9-10):925-6. PubMed ID: 7273032
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 12. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy.
    Noonan FP; Halliday WJ; Wall DR; Clunie GJ
    Cancer Res; 1977 Aug; 37(8 Pt 1):2473-80. PubMed ID: 872076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum.
    Tan SG; Cotterill JA; Roberts MM; Cunliffe WJ
    Acta Derm Venereol; 1978; 58(6):551-3. PubMed ID: 83086
    [No Abstract]   [Full Text] [Related]  

  • 17. [Monitoring natural killer cell activity in the blood of patients with malignant pleural effusion after intrapleural administration of Corynebacterium parvum].
    Marel M; Pospísil M; Fiserová A; Melínová L; Skácel Z; Bednár M
    Cas Lek Cesk; 1990 Apr; 129(16):498-500. PubMed ID: 2340567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corynebacterium parvum antibodies in healthy and cancer patients.
    Hardas U; Jalgaonkar SV; Chatterjee AK
    Indian J Cancer; 1982; 19(2):113-5. PubMed ID: 7129515
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I study of corynebacterium parvum in patients with solid tumors.
    Band PR; Jao-King C; Urtasun RC; Haraphongse M
    Cancer Chemother Rep; 1975; 59(6):1139-45. PubMed ID: 769953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corynebacterium parvum.
    Delmonte L; Oettgen HF; Hirshaut Y; Pinsky CM; Wanebo HJ
    Clin Bull; 1976; 6(1):31-4. PubMed ID: 1269143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.